Related Experiment Video
Updated: Nov 10, 2025

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
Role of exosomal miRNAs in brain metastasis affected by radiotherapy
Zihuang Li1, Hongli Yang1, Ling Ye2
1Department of Radiation Oncology, The Second Clinical Medical College of Jinan University, Shenzhen Municipal People's Hospital, 1017 Dongmen North Road, Shenzhen, Guangdong, 518020, China.
Abstract:
In oncogenesis and development of malignant tumor, microRNAs (miRNAs) regulate the complex gene expression associated with the tumor pathogenesis. Currently, only few studies have been conducted to identify miRNAs and the potential pathways involved in the pathogenesis of brain metastasis in patients who underwent radiotherapy, especially miRNAs in the plasma exosomes. Therefore, this study is aimed to use small RNA analysis to identify miRNAs and their potential target genes in plasma exosomes during the initiation and development of brain metastasis in patients who underwent radiotherapy. Using high-throughput sequencing technologies, we identified 35 differentially expressed miRNAs in patients with brain metastasis who had undergone radiotherapy. In annotation of miRNA targets, gene ontology enrichment analysis revealed that the targets of the differentially expressed miRNAs were significantly enriched in the regulation of cellular processes. Kyoto Encyclopedia of Genes and Genomes revealed that most of the miRNA targets were cancer-related, including genes involved in the mitogen-activated protein kinase signaling pathway, cancer-related pathways, phosphatidylinositol 3-kinase-protein kinase B signaling pathway, microtubule-associated protein kinase signaling pathway, Ras signaling pathway, regulation of the actin cytoskeleton, and axon guidance. In conclusion, this study provides a new perspective to understand the possible function of these miRNAs in the pathogenesis of brain metastasis. This was the first time that a pilot study identified plasma exosomal miRNAs in five patients with brain metastasis before and after radiotherapy. This study is the beginning; more specimen and further research are needed to explore the functional role of specific miRNAs and their potential as therapeutic targets for brain metastasis.
Insights
This study identified 35 differentially expressed microRNAs (miRNAs) in plasma exosomes of patients with brain metastasis after radiotherapy. These miRNAs may play a role in cancer-related pathways, offering potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression in oncogenesis and tumor development.
- Limited research exists on miRNAs in plasma exosomes related to brain metastasis following radiotherapy.
Purpose of the Study:
- To identify microRNAs (miRNAs) and their target genes in plasma exosomes during brain metastasis development in radiotherapy patients.
- To explore the role of these miRNAs in cancer-related signaling pathways.
Main Methods:
- Small RNA sequencing was employed to analyze plasma exosomal miRNAs.
- Bioinformatic analyses, including Gene Ontology and Kyoto Encyclopedia of Genes and Genomes, were used for target gene annotation and pathway analysis.
Main Results:
- 35 differentially expressed miRNAs were identified in patients with brain metastasis post-radiotherapy.
- Enrichment analysis revealed miRNA targets involved in cellular processes and key cancer pathways (e.g., MAPK, PI3K-Akt, Ras signaling).
Conclusions:
- This pilot study provides novel insights into the function of plasma exosomal miRNAs in brain metastasis pathogenesis after radiotherapy.
- Identified miRNAs represent potential therapeutic targets, warranting further investigation with larger sample sizes.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs

